Results 1 to 10 of about 24,931 (209)

Comparison of peritoneal dialysis and hemodialysis as first renal replacement therapy in patients with end-stage renal disease and diabetes: a systematic review

open access: yesRenal Replacement Therapy, 2019
Background Diabetes has become the most common cause of end-stage renal disease (ESRD) requiring renal replacement therapy (RRT) in most countries around the world.
Yukio Maruyama   +9 more
doaj   +1 more source

Intrarenal and Urinary Glycogen Synthase Kinase-3 Beta Levels in Diabetic and Nondiabetic Chronic Kidney Disease

open access: yesKidney & Blood Pressure Research, 2023
Background: Renal glycogen synthase kinase-3 beta (GSK3β) overactivity has been associated with a diverse range of kidney diseases. GSK3β activity in urinary exfoliated cells was reported to predict the progression of diabetic kidney disease (DKD).
Lingfeng Zeng   +5 more
doaj   +1 more source

Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report

open access: yesBMC Nephrology, 2018
Background Icodextrin is a starch-derived, water soluble glucose polymer, which is used as an alternative to glucose in order to enhance dialytic fluid removal in peritoneal dialysis patients.
Vassilios Liakopoulos   +5 more
doaj   +1 more source

High intraperitoneal interleukin-6 levels predict ultrafiltration (UF) insufficiency in peritoneal dialysis patients: A prospective cohort study

open access: yesFrontiers in Medicine, 2022
IntroductionUF insufficiency is a major limitation in PD efficiency and sustainability. Our study object to investigate the efficacy of intraperitoneal inflammation marker, IL-6 level as a predictor of UF insufficiency in continuous ambulatory peritoneal
Qianhui Song   +19 more
doaj   +1 more source

Calciphylaxis: A successful outcome whilst on peritoneal dialysis

open access: yesBulletin de la Dialyse à Domicile, 2019
Calciphylaxis is a life threatening disease for which patients with chronic kidney disease, particular those on dialysis, are at increased risk. As it is a rare condition, treatment options are limited and duration of treatment is not clear, especially ...
Ana Gaspar   +5 more
doaj   +1 more source

Urinary mitochondrial DNA level as a biomarker of tissue injury in non-diabetic chronic kidney diseases

open access: yesBMC Nephrology, 2018
Background Urinary mitochondrial DNA (mtDNA) fragment level has been proposed as a biomarker of chronic kidney disease (CKD). In this study, we determine the relation between urinary mtDNA level and rate of renal function deterioration in non-diabetic ...
Zhongping WEI   +7 more
doaj   +1 more source

Adipose and serum zinc alpha-2-glycoprotein (ZAG) expressions predict longitudinal change of adiposity, wasting and predict survival in dialysis patients

open access: yesScientific Reports, 2022
There were limited data on adipose and serum zinc alpha-2-glycoprotein (ZAG) expression and its association with body composition in patients with advanced chronic kidney disease (CKD).
Gordon Chun-Kau Chan   +13 more
doaj   +1 more source

Peritoneal Dialysis–Associated Peritonitis [PDF]

open access: yesClinical Journal of the American Society of Nephrology, 2019
Peritonitis is a common and severe complication in peritoneal dialysis (PD). Detailed recommendations on the prevention and treatment of PD-associated peritonitis have been published by the International Society for Peritoneal Dialysis (ISPD), but there is a substantial variation in clinical practice among dialysis units.
Cheuk-Chun Szeto, Philip Kam-Tao Li
openaire   +2 more sources

The Peritoneal Dialysis System [PDF]

open access: yesNephrology Dialysis Transplantation, 1998
flow by a few ml/day to achieve much higher clear-ances and, consequently, significant increases in Kt/V.The evolution of peritoneal dialysis techniques has However, while theoretically possible, this would notpermitted not only the survival of uraemic patients, be feasible in practice since it would mean carryingbut also a remarkable rehabilitation and ...
Ronco C, Brendolan A, La Greca G
openaire   +2 more sources

HIF1α-BNIP3-mediated mitophagy protects against renal fibrosis by decreasing ROS and inhibiting activation of the NLRP3 inflammasome

open access: yesCell Death and Disease, 2023
Chronic kidney disease affects approximately 14.3% of people worldwide. Tubulointerstitial fibrosis is the final stage of almost all progressive CKD. To date, the pathogenesis of renal fibrosis remains unclear, and there is a lack of effective treatments,
Jialin Li   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy